UnitedHealth Group Incorporated(UNH) - Stock detail

UnitedHealth Group Incorporated

US
UNH
UnitedHealth Group Incorporated(Listing date: 10/19/1984)

UnitedHealth Group Incorporated is a Delaware corporation. It is a diversified company dedicated to helping people live healthy lives and work better. The company provides a wide range of products and services through two distinct platforms: UnitedHealthcare, which offers healthcare coverage and benefit services; and Optum, which provides information and technology-enabled health services.

AI Rating

Rating methodology
Latest close (chg%)377.00-0.24%
Buy price
350.00
Target price390.00
Sell price350.00
P/E TTM27.96
P/E21.96
Confidence70%
Risk score60/100
AI Summary
The committee reaffirms a Hold recommendation due to converging headwinds (Massachusetts lawsuit creating regulatory uncertainty, technical weakness, and margin pressure) that make a Buy premature, but the long-term bullish thesis remains intact and no critical support ($350) has been broken to warrant a Sell. Existing positions should be held defensively while awaiting clearer signals.

Alpha Score

0-10
  • Trend（Score 4/10）

    UNH is undergoing a technical correction after a strong rally, with short-term momentum bearish but long-term trend structure still positive, recommending existing holders maintain positions while new entrants wait for reversal signals.

  • Valuation（Score 5/10）

    Valuation presents mixed signals with a low Price-to-Sales ratio being attractive while P/E is in a fair-to-full range. The stock is assessed as fairly valued at the current price of $377, which aligns closely with the fundamental target price of $375 and sits within the reasonable price range of $340-$410.

  • Financial strength（Score 3/10）
    Financial health shows both strengths and areas of concern. The company maintains massive scale with over $447B in annual revenue, but faces high financial leverage and tight liquidity that require close monitoring of cash flow and debt management.
  • Profitability（Score 4/10）
    Profitability metrics show a mixed picture with recent quarterly results indicating pressure on margins. While revenue growth has been healthy annually, net income and gross profit have declined significantly, suggesting margin compression from rising costs.
  • Sentiment（Score 2/10）
    UnitedHealth faces a significant negative catalyst from a major Medicaid fraud lawsuit in Massachusetts, which is expected to dominate short-term price action and outweigh positive operational improvements.
Latest price
$377.00-0.24%
Market cap342.37B
P/E TTM27.96
P/E21.96
Volume6.8M
Turnover2.57B